EUVIMEDEUVIMED entdecken
Open Access

Long noncoding RNA PVT1: potential oncogene in the development of acute lymphoblastic leukemia

Narjes Yazdi iD, Mohammad Houshmand iD, Amir Atashi iD, Alireza Kazemi iD, Ali Anjam Najmedini iD, Mahin Nikougoftar Zarif iD

TURKISH JOURNAL OF BIOLOGY · 25.10.2018 · 42 (5) · 405-413

DOI: 10.3906/biy-1801-46 ↗

Kurz gefasst

Fachartikel in der Zeitschrift TURKISH JOURNAL OF BIOLOGY, online erschienen am 25.10.2018. Verfasst von Narjes Yazdi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Genetics, Tehran Medical Branch, Islamic Azad University , Tehran , Iran. Die Arbeit wurde bisher 26-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Emerging evidence shows that long noncoding RNAs (lncRNAs) participate in various cellular processes, and that plasmacytoma variant translocation 1 (PVT1), a newly described oncogene that interacts with various molecules such as p15, p16, NOP2, and c-Myc, is a major contributing factor in tumor development. However, the role of this oncogene remains unknown in the pathogenesis of acute lymphoblastic leukemia (ALL), the most prevalent form of childhood leukemia. In this study, we first measure the expression level of PVT1 in a Jurkat cell line, then small interfering (siRNA) PVT1 is applied to demonstrate the impact of PVT1 knockdown in apoptosis, proliferation, the cell cycle, and its downstream targets. Our findings show that lncRNA was significantly higher in the ALL cell line than normal lymphocytes and that PVT1 knock-down increased the rate of apoptosis, caused G0/G1 arrest in the cell cycle, reduced the proliferation rate, and, above all, reduced the stability of c-Myc protein. All findings were confirmed at the molecular level. Our results may indicate the role of PVT1 knock-down in the suppression of ALL development and might provide an option for targeted therapy for leukemic conditions.

Schlagwörter

Stichwörter der Autor:innen

Long noncoding RNAPVT1acute lymphoblastic leukemiac-MycsiRNA

Autor:innen und Institutionen

  • Department of Molecular Genetics, Tehran Medical Branch, Islamic Azad University , Tehran , Iran.
  • Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine , Tehran , Iran.
  • Stem Cell and Tissue Engineering Research Center, Shahroud University of Medical Sciences , Shahroud , Iran.
  • Department of Hematology and Blood Banking, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences , Tehran , Iran.

ORCID-Profile: Narjes Yazdi, Mohammad Houshmand, Amir Atashi, Alireza Kazemi, Ali Anjam Najmedini, Mahin Nikougoftar Zarif

Zitieren

APA

Yazdi, N., Houshmand, M., Atashi, A., Kazemi, A., Najmedini, A. A., & Zarif, M. N. (2018). Long noncoding RNA PVT1: potential oncogene in the development of acute lymphoblastic leukemia. TURKISH JOURNAL OF BIOLOGY, 42(5), 405-413. https://doi.org/10.3906/biy-1801-46

Vancouver

Yazdi N, Houshmand M, Atashi A, Kazemi A, Najmedini AA, Zarif MN. Long noncoding RNA PVT1: potential oncogene in the development of acute lymphoblastic leukemia. TURKISH JOURNAL OF BIOLOGY. 2018;42(5):405-413. doi:10.3906/biy-1801-46

BibTeX
@article{Yazdi2018,
  author = {Yazdi, Narjes and Houshmand, Mohammad and Atashi, Amir and Kazemi, Alireza and Najmedini, Ali Anjam and Zarif, Mahin Nikougoftar},
  title = {Long noncoding RNA PVT1: potential oncogene in the development of acute lymphoblastic leukemia},
  journal = {TURKISH JOURNAL OF BIOLOGY},
  year = {2018},
  volume = {42},
  number = {5},
  pages = {405--413},
  doi = {10.3906/biy-1801-46}
}
Kostenlos starten →